Drugs / Bacillus thuringiensis israelensis
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06870344 | Mar 2025 → Jul 2026 overdue | Plasmodium falciparum malaria | University of North Carolina, Chapel Hill | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bacillus thuringiensis israelensis | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06870344 ↗ |
| Known as | Bti | “The biologic larvicide Bacillus thuringiensis israelensis (Bti) is non-toxic to mammals, birds, and fish.” NCT06870344 ↗ |